Thursday, Dec 21, 2023 · SEC filings
What the smart money revealed on Dec 21
524 insider filings came in. We hid 72 planned (10b5-1) sellers and 292 people whose filings were routine, like grants and tax withholding.
SinglePoint (SING) CEO Wil Ralston bought $500K
100,000 shares on the open market. Not a grant or an option exercise.
Calamos Long/Short Equity & Dynamic Income Trust (CPZ) President and Chairman John Calamos Sr. bought $267K
18,000 shares on the open market. Not a grant or an option exercise.
Nucor (NUE) Director Nicholas Gangestad bought $177K
1,000 shares on the open market. Not a grant or an option exercise. Their past buys: 1 of 3 checked quarters beat the typical stock 6 months later.
TScan Therapeutics (TCRX) Director Timothy Barberich bought $143K
29,147 shares on the open market. Not a grant or an option exercise.
Surgery Partners (SGRY) Director T. Devin O'Reilly sold $262M
Not marked as a planned 10b5-1 sale. Sold 13% of the shares they held directly. Still holds 50.42M shares.
Cooper Companies (COO) Director Robert Weiss sold $29M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 70,693 shares directly.
Prologis (PLD) Director James Connor sold $16.6M
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 19 more real buys
Show 97 more real sales
13F season
Holdings as of Sep 30, 2023 were due Nov 14
40 funds have filed. 40 filed for the quarter before.
Biggest real insider buys, Dec 15–21
Open-market buys by officers and directors, filed in the 7 days up to Dec 21.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.